Not too sure about Sandoz due diligence . Any half smart scientist knows there are better compounds to increase cbd solubility . By better I mean , less expensive , FDA approved , readily available pharmaceutical grade etc . The two earlier trials were never published or therefore peer reviewed and validated Its possible that Sandoz are just interested in hopefully a successful trial ( with a financial boost ?) to establish their own highly soluble cbd insomnia product . Why pay licence fees , royalties etc when you can use a better generic cbd solubilizer ? This is the eternal tpm problem , it offers nothing better than what's readily available . flogging a dead horse , imo
AVE Price at posting:
0.6¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)